MA34548B1 - Formes solides d'un inhibiteur puissant du vhc - Google Patents
Formes solides d'un inhibiteur puissant du vhcInfo
- Publication number
- MA34548B1 MA34548B1 MA35773A MA35773A MA34548B1 MA 34548 B1 MA34548 B1 MA 34548B1 MA 35773 A MA35773 A MA 35773A MA 35773 A MA35773 A MA 35773A MA 34548 B1 MA34548 B1 MA 34548B1
- Authority
- MA
- Morocco
- Prior art keywords
- powerful
- solid forms
- hcv inhibitor
- hcv
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Abstract
Cette invention concerne de nouvelles formes de sels de sodium du composé (1) suivant et leurs méthodes de préparation, des compositions pharmaceutiques associées et leur utilisation dans le traitement d'une infection par le virus de l'hépatite C (VHC).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38824210P | 2010-09-30 | 2010-09-30 | |
PCT/US2011/052869 WO2012044520A1 (fr) | 2010-09-30 | 2011-09-23 | Formes solides d'un inhibiteur puissant du vhc |
Publications (1)
Publication Number | Publication Date |
---|---|
MA34548B1 true MA34548B1 (fr) | 2013-09-02 |
Family
ID=44759789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA35773A MA34548B1 (fr) | 2010-09-30 | 2011-09-23 | Formes solides d'un inhibiteur puissant du vhc |
Country Status (21)
Country | Link |
---|---|
US (2) | US8598183B2 (fr) |
EP (1) | EP2621921A1 (fr) |
JP (1) | JP2013543495A (fr) |
KR (1) | KR20130108326A (fr) |
CN (1) | CN103153987A (fr) |
AP (1) | AP2013006733A0 (fr) |
AR (1) | AR083256A1 (fr) |
AU (1) | AU2011307346A1 (fr) |
BR (1) | BR112013007700A2 (fr) |
CA (1) | CA2813179A1 (fr) |
CL (1) | CL2013000578A1 (fr) |
CO (1) | CO6700844A2 (fr) |
EA (1) | EA201300422A1 (fr) |
EC (1) | ECSP13012552A (fr) |
MA (1) | MA34548B1 (fr) |
MX (1) | MX2013003551A (fr) |
PE (1) | PE20131351A1 (fr) |
SG (1) | SG188376A1 (fr) |
TW (1) | TW201307327A (fr) |
UY (1) | UY33632A (fr) |
WO (1) | WO2012044520A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA34548B1 (fr) * | 2010-09-30 | 2013-09-02 | Boehringer Ingelheim Int | Formes solides d'un inhibiteur puissant du vhc |
SI2787998T1 (sl) * | 2011-12-06 | 2017-02-28 | Sanofi | Kristalinične oblike 2-(2-metilamino-pirimidin-4-il)-1H-indol-5-karboksilne kisline ((S)-1- karbamoil-2-(fenil-pirimidin-2-il-amino)etil)-amida |
US20130261134A1 (en) * | 2012-03-30 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Mesylate salt forms of a potent hcv inhibitor |
WO2014138374A1 (fr) | 2013-03-08 | 2014-09-12 | Boehringer Ingelheim International Gmbh | Polythérapie par voie orale pour le traitement d'une infection par le vhc chez une sous-population spécifique de patients |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1033128T2 (sl) | 1993-09-28 | 2012-02-29 | Scherer Gmbh R P | Izdelava mehke Ĺľelatinaste kapsule |
US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
EP2335700A1 (fr) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Inhibiteurs de la polymerase du virus hepatitis C avec une structure heterobicylic |
DK1718608T3 (da) | 2004-02-20 | 2013-10-14 | Boehringer Ingelheim Int | Virale polymeraseinhibitorer |
AU2006213769B2 (en) | 2005-02-11 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Process for preparing 2,3-disubstituted indoles |
AU2006340003A1 (en) | 2005-11-09 | 2007-09-20 | Novartis Ag | Process for making pharmaceutical compositions with a transient plasticizer |
MA34548B1 (fr) * | 2010-09-30 | 2013-09-02 | Boehringer Ingelheim Int | Formes solides d'un inhibiteur puissant du vhc |
-
2011
- 2011-09-23 MA MA35773A patent/MA34548B1/fr unknown
- 2011-09-23 SG SG2013015854A patent/SG188376A1/en unknown
- 2011-09-23 AP AP2013006733A patent/AP2013006733A0/xx unknown
- 2011-09-23 US US13/241,551 patent/US8598183B2/en active Active
- 2011-09-23 PE PE2013000628A patent/PE20131351A1/es not_active Application Discontinuation
- 2011-09-23 EA EA201300422A patent/EA201300422A1/ru unknown
- 2011-09-23 AU AU2011307346A patent/AU2011307346A1/en not_active Abandoned
- 2011-09-23 MX MX2013003551A patent/MX2013003551A/es not_active Application Discontinuation
- 2011-09-23 JP JP2013531669A patent/JP2013543495A/ja active Pending
- 2011-09-23 CA CA2813179A patent/CA2813179A1/fr not_active Abandoned
- 2011-09-23 EP EP11764925.1A patent/EP2621921A1/fr not_active Withdrawn
- 2011-09-23 KR KR1020137008249A patent/KR20130108326A/ko not_active Application Discontinuation
- 2011-09-23 WO PCT/US2011/052869 patent/WO2012044520A1/fr active Application Filing
- 2011-09-23 BR BR112013007700A patent/BR112013007700A2/pt not_active IP Right Cessation
- 2011-09-23 CN CN2011800471790A patent/CN103153987A/zh active Pending
- 2011-09-29 UY UY0001033632A patent/UY33632A/es unknown
- 2011-09-29 AR ARP110103617A patent/AR083256A1/es unknown
- 2011-09-29 TW TW100135337A patent/TW201307327A/zh unknown
-
2013
- 2013-02-28 CL CL2013000578A patent/CL2013000578A1/es unknown
- 2013-03-22 CO CO13057890A patent/CO6700844A2/es unknown
- 2013-04-15 EC ECSP13012552 patent/ECSP13012552A/es unknown
- 2013-10-30 US US14/067,218 patent/US20140057928A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TW201307327A (zh) | 2013-02-16 |
JP2013543495A (ja) | 2013-12-05 |
AR083256A1 (es) | 2013-02-13 |
US8598183B2 (en) | 2013-12-03 |
SG188376A1 (en) | 2013-04-30 |
MX2013003551A (es) | 2013-05-01 |
CN103153987A (zh) | 2013-06-12 |
US20140057928A1 (en) | 2014-02-27 |
WO2012044520A1 (fr) | 2012-04-05 |
UY33632A (es) | 2012-04-30 |
CL2013000578A1 (es) | 2013-08-02 |
AP2013006733A0 (en) | 2013-02-28 |
ECSP13012552A (es) | 2013-06-28 |
AU2011307346A1 (en) | 2013-02-21 |
US20120122887A1 (en) | 2012-05-17 |
BR112013007700A2 (pt) | 2019-09-24 |
KR20130108326A (ko) | 2013-10-02 |
EA201300422A1 (ru) | 2013-09-30 |
PE20131351A1 (es) | 2013-12-04 |
EP2621921A1 (fr) | 2013-08-07 |
CO6700844A2 (es) | 2013-06-28 |
CA2813179A1 (fr) | 2012-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA33731B1 (fr) | Inhibiteurs du virus de l'hépatite c | |
EA201201031A1 (ru) | Ингибиторы вируса гепатита с | |
EA200901241A1 (ru) | Соединения для лечения гепатита с | |
EA200800178A1 (ru) | Ингибиторы вируса гепатита с (hcv) | |
ATE551337T1 (de) | Inhibitoren des hepatitis-c-virus | |
ATE547103T1 (de) | Hemmer des hepatitis-c-virus | |
MA34896B1 (fr) | Inhibiteurs du virus de l'hepatite c | |
EA201491179A1 (ru) | 2',4'-дифтор-2'-метил замещенные нуклеозидные производные в качестве ингибиторов репликации рнк вируса гепатита с | |
MA37712B1 (fr) | Inhibiteurs macrocycliques de virus flaviviridae | |
EA201171208A1 (ru) | Ингибиторы вируса гепатита с | |
MY160130A (en) | Hepatitis c virus inhibitors | |
NZ708392A (en) | Functionalized benzamide derivatives as antiviral agents against hbv infection | |
EA201001273A1 (ru) | Ингибиторы вируса гепатита с | |
EA201101082A1 (ru) | Ингибиторы вируса гепатита с | |
MA33806B1 (fr) | Inhibiteurs du virus de l'hepatite c | |
EA201170915A1 (ru) | Фосфорамидатные производные гуанозиновых нуклеозидов для лечения вирусных инфекций | |
EA200900298A1 (ru) | Ингибиторы вируса гепатита с | |
EP2555622A4 (fr) | Inhibiteurs du virus de l'hépatite c | |
EA201290053A1 (ru) | Ингибиторы вирусов flaviviridae | |
EA201000277A1 (ru) | Соединения для лечения гепатита с | |
MA35109B1 (fr) | Derives de nucleoside 2-substitues et procedes d'utilisation de ceux-ci pour le traitement de maladies virales | |
EA201370017A1 (ru) | Ингибиторы вируса гепатита с | |
EA201390190A1 (ru) | Ингибиторы вируса гепатита с | |
EA201290575A1 (ru) | Ингибиторы вирусов flaviviridae | |
EA201290576A1 (ru) | Ингибиторы вирусов flaviviridae |